Equity Overview
Price & Market Data
Price: $11.69
Daily Change: -$0.36 / 3.08%
Daily Range: $11.51 - $12.22
Market Cap: $362,650,720
Daily Volume: 658,822
Performance Metrics
1 Week: -10.64%
1 Month: -40.50%
3 Months: -57.44%
6 Months: -69.93%
1 Year: -53.53%
YTD: -27.56%
Company Details
Employees: 42
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.